Waypoint Bio Launches with $14.5M to Turbocharge Drug Discovery using in vivo Spatial Pooled Screening Technology
Company’s proprietary technology and lab-in-the-loop approach to be applied first to the discovery of novel, solid tumor cell therapies for cancers like pancreatic cancer Waypoint Bio Co-founders and CEO Xinchen Wang (L) and Chief Scientific…